One of the central questions in immunology is how a limited set of MHC class I molecules expressed in each individual can interact with a large number of different peptide antigens. Our objective of this proposal is to provide the structural basis of this broad but selective recognition of peptides with class I molecules by immunological, biochemical and biophysical approaches. The and in chemotherapy and drug design. The specific goal is to specify the detail interactions of murine MHC class I molecules with peptides and to determine their three-dimensional structures by x-ray crystallography. Significant immunological work has focussed on the mouse MHC system and this first detailed x-ray study of a mouse I, H-2Kb will be invaluable for analysis of the vast body of immunological data on antigen presentation and T-cell recognition (TCR).
The specific aims of our proposal are as follows: 1. Three-dimensional Structures of Kb-Peptide (8-9 mer) Complexes 2. Three-dimensional Structures of Kb with Longer Peptides 3. Three-dimensional Structures of Empty Kb Molecules 4. Biochemical and Crystallographic Analysis of Mutant Kb 5. Biochemical and Crystallographic Analysis of CD1, A Non-classical MHC Class I Molecule 6. Biochemical Analysis and Crystallization of Other Murine MHC Class I 7. Design and Characterization of MHC Class I Agonists and Antagonists A combined immunological, biochemical and biophysical approach will be used to understand the specific binding of viral, microbial and self peptides. The structures of the empty or unliganded Kb will show whether conformational changes in the MHC accompany peptide binding as has been, seen for example, in the binding of peptides for Fabs. The function of class I molecules will be probed by the analysis of murine class I mutants (H-2Kbm) as well as the study of a non-classical class I antigen, CD1. A further goal is to understand ad compare how other murine MHC1 molecules such as H-2Ld recognize and interact with peptides. The long term goal is to understand the biologically important signal transduction complexes of MHC, TCR and accessory molecules such as CD-8. This proposal represents a joint effort by two laboratories to elucidate the structure and function of murine MHC class I molecules.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA058896-05
Application #
2633842
Study Section
Biophysical Chemistry Study Section (BBCB)
Program Officer
Mccarthy, Susan A
Project Start
1994-01-01
Project End
1998-12-31
Budget Start
1998-01-01
Budget End
1998-12-31
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Grimster, Neil P; Connelly, Stephen; Baranczak, Aleksandra et al. (2013) Aromatic sulfonyl fluorides covalently kinetically stabilize transthyretin to prevent amyloidogenesis while affording a fluorescent conjugate. J Am Chem Soc 135:5656-68
Bulawa, Christine E; Connelly, Stephen; Devit, Michael et al. (2012) Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A 109:9629-34
Witherden, Deborah A; Watanabe, Megumi; Garijo, Olivia et al. (2012) The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal ?? T cell function. Immunity 37:314-25
Kasmar, Anne G; van Rhijn, Ildiko; Cheng, Tan-Yun et al. (2011) CD1b tetramers bind ?? T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med 208:1741-7
Verdino, Petra; Witherden, Deborah A; Podshivalova, Katie et al. (2011) cDNA sequence and Fab crystal structure of HL4E10, a hamster IgG lambda light chain antibody stimulatory for ?? T cells. PLoS One 6:e19828
Kirchdoerfer, Robert N; Garner, Amanda L; Flack, Caralyn E et al. (2011) Structural basis for ligand recognition and discrimination of a quorum-quenching antibody. J Biol Chem 286:17351-8
Verdino, Petra; Witherden, Deborah A; Ferguson, M Sharon et al. (2011) Molecular insights into ?? T cell costimulation by an anti-JAML antibody. Structure 19:80-9
Witherden, Deborah A; Verdino, Petra; Rieder, Stephanie E et al. (2010) The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation. Science 329:1205-10
Verdino, Petra; Witherden, Deborah A; Havran, Wendy L et al. (2010) The molecular interaction of CAR and JAML recruits the central cell signal transducer PI3K. Science 329:1210-4
Yoshida, Kenji; Corper, Adam L; Herro, Rana et al. (2010) The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity. J Clin Invest 120:1578-90

Showing the most recent 10 out of 88 publications